HPV Vaccination Initiation Among White, Black and Middle East North African (MENA) Males

Overview

Journal Prev Med Rep

Date 2022 Oct 25

PMID 36281349

Authors

Diane M Harper

Ryan Rego

Madiha Tariq

Minal R Patel

Kenneth Resnicow

Sherri Sheinfeld Gorin

Affiliations

Soon will be listed here.

Abstract

Objectives: US males initiate HPV vaccination at older ages than females and currently have low population coverage. We aim to describe the prevalence and predictors of HPV vaccination initiation among males of White, Black, and Middle-Eastern/North-African (MENA) descent in southeast Michigan.

Methods: We conducted three community-based surveys in 2019 that provided primary data via self report. Using population weights and multivariate modeling, we measured the prevalence and predictors of HPV vaccine initiation in each race/ethnicity of men (age 18-34 years) analyzed.

Results: The vaccine initiation rates were 44.5 % (95 % CI: 44.4, 44.6) for White men, 46.2 % (46.0, 46.4) for Black men, and 23.2 % (22.8, 23.6) for MENA men, (p < 0.001). Being a student, compared to unemployed or disabled, was significantly associated with HPV vaccine initiation across all three races/ethnicities. Married men of any race/ethnicity were unlikely to be vaccinated. MENA men born in the US and having some college education were also more likely to initiate HPV vaccination.

Conclusions: White, Black, and MENA men are not vaccinated in accord with Healthy (Healthy People 2030, 2022) goals. Each race/ethnicity has different predictors of vaccination.

Citing Articles

A Systematic Review of Knowledge, Attitudes, and Factors Influencing HPV Vaccine Acceptance Among Adolescents, Parents, Teachers, and Healthcare Professionals in the Middle East and North Africa (MENA) Region.

Vincent S, Al Yaquobi S, Al Hashmi A Cureus. 2024; 16(5):e60293.

PMID: 38872638 PMC: 11175019. DOI: 10.7759/cureus.60293.

References

Rolnick S, Parker E, Nordin J, Hedblom B, Wei F, Kerby T . Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?. Vaccine. 2013; 31(37):3928-35. PMC: 4689428. DOI: 10.1016/j.vaccine.2013.06.041. View

Lu P, Hung M, Srivastav A, Grohskopf L, Kobayashi M, Harris A . Surveillance of Vaccination Coverage Among Adult Populations -United States, 2018. MMWR Surveill Summ. 2021; 70(3):1-26. PMC: 8162796. DOI: 10.15585/mmwr.ss7003a1. View

Harper D, Tariq M, Alhawli A, Syed N, Patel M, Resnicow K . Cancer risk perception and physician communication behaviors on cervical cancer and colorectal cancer screening. Elife. 2021; 10. PMC: 8384416. DOI: 10.7554/eLife.70003. View

Boersma P, Black L . Human Papillomavirus Vaccination Among Adults Aged 18-26, 2013-2018. NCHS Data Brief. 2020; (354):1-8. View

Thompson E, Rosen B, Maness S . Social Determinants of Health and Human Papillomavirus Vaccination Among Young Adults, National Health Interview Survey 2016. J Community Health. 2018; 44(1):149-158. DOI: 10.1007/s10900-018-0565-2. View

Thompson E, Vamos C, Vazquez-Otero C, Logan R, Griner S, Daley E . Trends and predictors of HPV vaccination among U.S. College women and men. Prev Med. 2016; 86:92-8. DOI: 10.1016/j.ypmed.2016.02.003. View

Fontenot H, Fantasia H, Charyk A, Sutherland M . Human papillomavirus (HPV) risk factors, vaccination patterns, and vaccine perceptions among a sample of male college students. J Am Coll Health. 2013; 62(3):186-92. DOI: 10.1080/07448481.2013.872649. View

Liao C, Francoeur A, Kapp D, Caesar M, Huh W, Chan J . Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017. JAMA Netw Open. 2022; 5(3):e222530. PMC: 8928005. DOI: 10.1001/jamanetworkopen.2022.2530. View

Resnicow K, Patel M, Green M, Smith A, Bacon E, Goodell S . The Association of Unfairness with Mental and Physical Health in a Multiethnic Sample of Adults: Cross-sectional Study. JMIR Public Health Surveill. 2021; 7(5):e26622. PMC: 8145085. DOI: 10.2196/26622. View

10.

Adjei Boakye E, Zeng W, Governor S, Nagendra S, Tobo B, Simpson M . Differences in human papillomavirus (HPV) vaccine uptake by nativity status among men aged 18-34 years. Prev Med Rep. 2019; 16:101010. PMC: 6883324. DOI: 10.1016/j.pmedr.2019.101010. View

11.

Pingali C, Yankey D, Elam-Evans L, Markowitz L, Williams C, Fredua B . National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020. MMWR Morb Mortal Wkly Rep. 2021; 70(35):1183-1190. PMC: 8422873. DOI: 10.15585/mmwr.mm7035a1. View

12.

Chen M, Mott N, Clark S, Harper D, Shuman A, Prince M . HPV Vaccination Among Young Adults in the US. JAMA. 2021; 325(16):1673-1674. PMC: 8080227. DOI: 10.1001/jama.2021.0725. View

13.

Meites E, Szilagyi P, Chesson H, Unger E, Romero J, Markowitz L . Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2019; 68(32):698-702. PMC: 6818701. DOI: 10.15585/mmwr.mm6832a3. View

14.

Adjei Boakye E, Lew D, Muthukrishnan M, Tobo B, Rohde R, Varvares M . Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States. Hum Vaccin Immunother. 2018; 14(8):2016-2024. PMC: 6150015. DOI: 10.1080/21645515.2018.1467203. View

15.

. QuickStats: Percentage* of Adults Aged 18-26 Years Who Ever Received a Human Papillomavirus Vaccine, by Race and Hispanic Origin and Sex - National Health Interview Survey, United States, 2019. MMWR Morb Mortal Wkly Rep. 2021; 70(21):797. PMC: 8158890. DOI: 10.15585/mmwr.mm7021a5. View

16.

Thomas R, Higgins L, Ding L, Widdice L, Chandler E, Kahn J . Factors Associated With HPV Vaccine Initiation, Vaccine Completion, and Accuracy of Self-Reported Vaccination Status Among 13- to 26-Year-Old Men. Am J Mens Health. 2016; 12(4):819-827. PMC: 5127783. DOI: 10.1177/1557988316645155. View

17.

Oliveira C, Avni-Singer L, Badaro G, Sullivan E, Sheth S, Shapiro E . Feasibility and Accuracy of a Computer-Assisted Self-Interviewing Instrument to Ascertain Prior Immunization With Human Papillomavirus Vaccine by Self-Report: Cross-Sectional Analysis. JMIR Med Inform. 2020; 8(1):e16487. PMC: 7003116. DOI: 10.2196/16487. View

18.

Lewis R, Markowitz L . Human papillomavirus vaccination coverage among females and males, National Health and Nutrition Examination Survey, United States, 2007-2016. Vaccine. 2018; 36(19):2567-2573. PMC: 5993427. DOI: 10.1016/j.vaccine.2018.03.083. View

19.

Meites E, Kempe A, Markowitz L . Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016; 65(49):1405-1408. DOI: 10.15585/mmwr.mm6549a5. View

20.

Harper D, Plegue M, Sen A, Gorin S, Jimbo M, Patel M . Predictors of screening for cervical and colorectal cancer in women 50-65 years old in a multi-ethnic population. Prev Med Rep. 2021; 22:101375. PMC: 8086134. DOI: 10.1016/j.pmedr.2021.101375. View